Sandoz Group AG | WebDisclosure

Basculer en Français

10020	Companies
203496	Keywords
133944	Articles
107981	Press releases

Home
Companies
Sandoz Group AG

BRIEF

published on 11/17/2025 at 07:05, 3 months 24 days ago

Sandoz lance le premier biosimilaire de la sclérose en plaques, TYRUKO®, aux États-Unis.

Sclérose En Plaques Biosimilaire Sandoz TYRUKO® Natalizumab
BRIEF

published on 11/17/2025 at 07:05, 3 months 24 days ago

Sandoz Launches First MS Biosimilar TYRUKO® in US

Multiple Sclerosis Biosimilar Sandoz TYRUKO® Natalizumab
PRESS RELEASE

published on 11/17/2025 at 07:00, 3 months 24 days ago

Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
Sandoz launches TYRUKO® (natalizumab-sztn) in US, the first and only multiple sclerosis biosimilar, offering cost-effective treatment. TYRUKO® approved for all indications of reference medicine Tysabri®

US Market Multiple Sclerosis Biosimilar Sandoz TYRUKO
BRIEF

published on 11/12/2025 at 07:40, 3 months 29 days ago

Sandoz Secures Global License for Breast Cancer Biosimilar

Oncology Biosimilar Breast Cancer Sandoz Pertuzumab
BRIEF

published on 11/12/2025 at 07:40, 3 months 29 days ago

Sandoz obtient une licence mondiale pour un biosimilaire du cancer du sein

Oncologie Biosimilaire Cancer Du Sein Sandoz Pertuzumab
PRESS RELEASE

published on 11/12/2025 at 07:35, 3 months 29 days ago

Sandoz signs global license agreement to commercialize breast cancer biosimilar pertuzumab
Sandoz signs global license agreement with EirGenix Inc. to commercialize biosimilar pertuzumab for HER2-positive breast cancer treatment, reinforcing its position in oncology

Agreement Biosimilar Breast Cancer Sandoz Pertuzumab
BRIEF

published on 11/04/2025 at 22:10, 4 months 6 days ago

Sandoz acquiert Just-Evotec Biologics pour développer ses capacités dans le domaine des biosimilaires.

Acquisition Biosimilaires Toulouse Sandoz Just-Evotec
BRIEF

published on 11/04/2025 at 22:10, 4 months 6 days ago

Sandoz Acquires Just-Evotec Biologics to Expand Biosimilars Capabilities

Acquisition Biosimilars Toulouse Sandoz Just-Evotec
PRESS RELEASE

published on 11/04/2025 at 22:05, 4 months 6 days ago

Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse
Sandoz strengthens biosimilars capabilities with acquisition of Just-Evotec Biologics EU SAS in Toulouse. Acquisition aims to capture projected biosimilar market opportunity. Transaction includes cash payment and technology license fees

Acquisition Biosimilars Sandoz Just-Evotec Biologics Continuous Manufacturing Technology
BRIEF

published on 10/30/2025 at 07:05, 4 months 12 days ago

Sandoz annonce une croissance de ses ventes et une révision à la hausse de ses prévisions de marge.

Croissance Des Ventes Biosimilaires Performance Régionale Orientation Financière Questions Commerciales

Accesswire

Published on 03/11/2026 at 13:00, 28 minutes ago

GameSquare Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
Published on 03/11/2026 at 12:30, 58 minutes ago

Algo Grande Identifies Additional Skarn Mineralization 3km South of Cerro Grande, With Samples Above 3% Copper and Confirms Copper in Multiple Targets on the Property
Published on 03/11/2026 at 12:30, 58 minutes ago

Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases
Published on 03/11/2026 at 12:23, 1 hour 5 minutes ago

SLAM Acquires New Copper Nickel Cobalt Showing Adjacent to Goodwin
Published on 03/11/2026 at 12:01, 1 hour 27 minutes ago

Northfield Capital Announces Planned Name Change to Juno International Corp.

View all ACCESSWIRE

EQS Group

Published on 03/11/2026 at 13:03, 25 minutes ago

NVIDIA and Nebius partner to scale full-stack AI cloud
Published on 03/11/2026 at 12:49, 39 minutes ago

Net Asset Value(s)
Published on 03/11/2026 at 12:30, 58 minutes ago

Wolftank Group successfully completes hydrogen infrastructure order for TPER – second refueling station in Bologna finalized
Published on 03/11/2026 at 12:25, 1 hour 3 minutes ago

MINISFORUM's N5 MAX Marks a Breakthrough in NAS Industry with Built-in OpenClaw in Local Computing
Published on 03/11/2026 at 12:05, 1 hour 23 minutes ago

Kasowitz LLP Publishes an Updated Report Examining the Fundamental Due Process Defects Underlying the Continued Detention and Prosecution of Erion Veliaj, the Mayor of Tirana, Albania

Les Echos

Published on 03/11/2026 at 12:07, 1 hour 20 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 3 mars 2026
Published on 03/11/2026 at 10:02, 3 hours 26 minutes ago

WEB SA - MODIFICATION AGENDA FINANCIER EXERCICE 2025
Published on 03/11/2026 at 08:00, 5 hours 28 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
Published on 03/11/2026 at 08:00, 5 hours 28 minutes ago

BIOPHYTIS ANNONCE LA REALISATION D’UNE LEVEE DE FONDS DE PLUS DE 2 MILLIONS D’EUROS ET LE REMBOURSEMENT DE L’INTEGRALITE DE SA DETTE CONVERTIBLE A PRIX VARIABLE
Published on 03/11/2026 at 07:00, 6 hours 28 minutes ago

TINC publishes excellent results with a record investment year as the basis for future profit growth

View all LES ECHOS COMFI WIRE